The Cooperative Induction of Hypoxia-Inducible Factor-1α and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis

被引:147
作者
Noman, Muhammad Zaeem
Buart, Stephanie
Van Pelt, Jos [2 ]
Richon, Catherine
Hasmim, Meriem
Leleu, Nathalie
Suchorska, Wictoria Maria
Jalil, Abdelali
Lecluse, Yann [3 ]
El Hage, Faten
Giuliani, Massimo [4 ]
Pichon, Christophe
Azzarone, Bruno [4 ]
Mazure, Nathalie [5 ]
Romero, Pedro [6 ]
Mami-Chouaib, Fathia
Chouaib, Salem [1 ]
机构
[1] Inst Gustave Roussy, INSERM, U753, F-94805 Villejuif, France
[2] Univ Hosp Gasthuisberg, Dept Hepatol, B-3000 Louvain, Belgium
[3] Inst Gustave Roussy PR2, Villejuif, France
[4] Univ Paris 11, Hop Paul Brousse, INSERM, UMR 542, Villejuif, France
[5] CNRS, Inst Signalling Dev Biol & Canc Res, UMR 6543, F-06034 Nice, France
[6] Ludwig Inst Canc Res, Div Clin Oncoimmunol, Lausanne, Switzerland
关键词
CYTOTOXIC T-LYMPHOCYTE; HUMAN LUNG-CARCINOMA; SIGNAL TRANSDUCERS; VEGF EXPRESSION; CANCER-THERAPY; FACTOR-ALPHA; HIF-1; IMMUNOTHERAPY; APOPTOSIS; TARGET;
D O I
10.4049/jimmunol.0800854
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hypoxia is an essential component of tumor microenvironment. In this study, we investigated the influence of hypoxia (1% PO2) on CTL-mediated tumor cell lysis. We demonstrate that exposure of target tumor cells to hypoxia has an inhibitory effect on the CTL clone (Heu171)-induced autologous target cell lysis. Such inhibition correlates with hypoxia-inducible factor-1 alpha (HIF-1 alpha) induction but is not associated with an alteration of CTL reactivity as revealed by granzyme B polarization or morphological change. Western blot analysis indicates that although hypoxia had no effect on p53 accumulation, it induced the phosphorylation of STAT3 in tumor cells by a mechanism at least in part involving vascular endothelial growth factor secretion. We additionally show that a simultaneous nuclear translocation of HIF-1 alpha and phospho-STAT3 was observed. Interestingly, gene silencing of STAT3 by small interfering RNA resulted in HIF-1 alpha inhibition and a significant restoration of target cell susceptibility to CTL-induced killing under hypoxic conditions by a mechanism involving at least in part down-regulation of AKT phosphorylation. Moreover, knockdown of HIF-1 alpha resulted in the restoration of target cell lysis under hypoxic conditions. This was further supported by DNA microarray analysis where STAT3 inhibition resulted in a partly reversal of the hypoxia-induced gene expression profile. The present study demonstrates that the concomitant hypoxic induction of phopho-STAT3 and HIF-1 alpha are functionally linked to the alteration of non-small cell lung carcinoma target susceptibility to CTL-mediated killing. Considering the eminent functions of STAT3 and HIF-1 alpha in the tumor microenvironment, their targeting may represent novel strategies for immunotherapeutic intervention. The Journal of Immunology, 2009, 182: 3510-3521.
引用
收藏
页码:3510 / 3521
页数:12
相关论文
共 56 条
  • [31] STAT3 can be activated through paracrine signaling in breast epithelial cells
    Lieblein, Jacqueline C.
    Ball, Sarah
    Hutzen, Brian
    Sasser, A. Kate
    Lin, Huey-Jen
    Huang, Tim H. M.
    Hall, Brett M.
    Lin, Jiayuh
    [J]. BMC CANCER, 2008, 8 (1)
  • [32] HIF-1α has an anti-apoptotic effect in human airway epithelium that is mediated via Mcl-1 gene expression
    Liu, XH
    Yu, EZ
    Li, YY
    Kagan, E
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 97 (04) : 755 - 765
  • [33] Cutting edge:: Hypoxia-inducible factor 1α and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes
    Lukashev, Dmitriy
    Klebanov, Boris
    Kojima, Hidefumi
    Grinberg, Alex
    Ohta, Akiko
    Berenfeld, Ludmilla
    Wenger, Roland H.
    Ohta, Akio
    Sitkovsky, Michail
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 177 (08) : 4962 - 4965
  • [34] Augmenting tumor sensitivity to topotecan by transient hypoxia
    Lund, EL
    Hansen, LT
    Kristjansen, PEG
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (05) : 473 - 480
  • [35] ENERGY-METABOLISM AND T-CELL-MEDIATED CYTOLYSIS .1. SYNERGISM BETWEEN INHIBITORS OF RESPIRATION AND GLYCOLYSIS
    MACDONALD, HR
    KOCH, CJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (03) : 699 - 709
  • [36] Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2:: a clinical report
    Marchand, M
    Punt, CJA
    Aamdal, S
    Escudier, B
    Kruit, WHJ
    Keilholz, U
    Håkansson, L
    van Baren, N
    Humblet, Y
    Mulders, P
    Avril, MF
    Eggermont, AMM
    Scheibenbogen, C
    Uiters, J
    Wanders, J
    Delire, M
    Boon, T
    Stoter, G
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (01) : 70 - 77
  • [37] Moeller BJ, 2004, CELL CYCLE, V3, P1107
  • [38] Synergy between tumor immunotherapy and antiangiogenic therapy
    Nair, S
    Boczkowski, D
    Moeller, B
    Dewhirst, M
    Vieweg, J
    Gilboa, E
    [J]. BLOOD, 2003, 102 (03) : 964 - 971
  • [39] Progress in the development of immunotherapy for the treatment of patients with cancer
    Rosenberg, SA
    [J]. JOURNAL OF INTERNAL MEDICINE, 2001, 250 (06) : 462 - 475
  • [40] Signal transduction to hypoxia-inducible factor 1
    Semenza, GL
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) : 993 - 998